Related Experiment Video
Updated: Jul 16, 2026
12:30
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
Retargeting gene delivery using surface-engineered retroviral vector particles
D Lavillette1, S J Russell, F L Cosset
1Laboratoire de Vectorologie Rétrovirale et Thérapie Génique, Unité de Virologie Humaine, INSERM U412, Ecole Normale Supérieure de Lyon, 46 allée d'Italie, 69364 Cedex 07, Lyon, France.
Current Opinion in Biotechnology
|October 18, 2001
Summary
Researchers are developing new strategies for retroviral vectors to improve gene delivery. These advanced vectors aim to overcome previous limitations in targeting specific tissues for in vivo gene transfer applications.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- Retroviral vectors are crucial for in vivo gene transfer, enabling targeted delivery of transgenes to specific tissues.
- Previous efforts to engineer vector host-range by surface ligand insertion often failed due to reduced vector fusogenicity upon binding target cells.
- This impairment of fusogenic activity hinders effective gene delivery in targeted applications.
Purpose of the Study:
- To explore novel strategies for enhancing the fusogenic activity of surface-engineered retroviral vectors.
- To overcome the limitations of previous host-range modification attempts.
- To enable more efficient and specific in vivo gene transfer.
Main Methods:
- Investigated various strategies to restore fusogenic activity in modified retroviral vector particles.
- Focused on surface engineering of vector glycoproteins.
- Explored novel concepts in retroviral vector design.
Main Results:
- Identified and explored several promising strategies to recover vector fusogenic activity.
- These strategies have led to the development of novel concepts in the field of retroviral vector engineering.
- Demonstrated potential for improved targeted gene delivery.
Conclusions:
- Novel strategies have been developed to overcome the fusogenicity issues in surface-engineered retroviral vectors.
- These advancements pave the way for more effective in vivo gene transfer applications.
- The field is progressing towards highly specific and efficient gene delivery systems.
